Literature DB >> 9002326

Anthrax: memorandum from a WHO meeting.

.   

Abstract

The risk of anthrax can be reduced through international collaboration in health education and training, promotion of research, and provision of scientific and technical advice. These issues were discussed by a WHO Working Group on Anthrax in September 1995, and this Memorandum presents their priority concerns and recommendations in several areas: surveillance, epidemiology, diagnosis in humans and in animals, prevention and control, and international cooperation.

Entities:  

Mesh:

Year:  1996        PMID: 9002326      PMCID: PMC2486867     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

Review 1.  Development of novel vaccines against anthrax in man.

Authors:  A V Stepanov; L I Marinin; A P Pomerantsev; N A Staritsin
Journal:  J Biotechnol       Date:  1996-01-26       Impact factor: 3.307

2.  Human live anthrax vaccine in the former USSR.

Authors:  E N Shlyakhov; E Rubinstein
Journal:  Vaccine       Date:  1994-06       Impact factor: 3.641

3.  [Retrospective diagnosis of anthrax by intradermal reaction].

Authors:  E Shlyakhov; E Rubinstein
Journal:  Med Trop (Mars)       Date:  1993 Jan-Mar
  3 in total
  1 in total

1.  The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax.

Authors:  Wun-Ju Shieh; Jeannette Guarner; Christopher Paddock; Patricia Greer; Kathleen Tatti; Marc Fischer; Marci Layton; Michael Philips; Eddy Bresnitz; Conrad P Quinn; Tanja Popovic; Bradley A Perkins; Sherif R Zaki
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.